• Something wrong with this record ?

New polyfluorothiopropanoyloxy derivatives of 5β-cholan-24-oic acid designed as drug absorption modifiers

L. Mrózek, L. Coufalová, L. Rárová, L. Plaček, R. Opatřilová, J. Dohnal, K. Kráľová, O. Paleta, V. Král, P. Drašar, J. Jampílek,

. 2013 ; 78 (9) : 832-44.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

A series of final six propanoyloxy derivatives of 5β-cholan-24-oic acid (tridecafluoroctylsulfanyl- and tridecafluoroctylsulfinylethoxycarbonylpropanoyloxy derivatives) as potential drug absorption promoters (skin penetration enhancers, intestinal absorption promoters) was generated by multistep synthesis. Structure confirmation of all generated compounds was accomplished by (1)H NMR, (13)C NMR, IR and MS spectroscopy methods. All the prepared compounds were analyzed using RP-TLC, and their lipophilicity (RM) was determined. The hydrophobicity (log P), solubility (logS), polar surface area (PSA) and molar volume (MV) of the studied compounds were also calculated. All the target compounds were tested for their in vitro transdermal penetration effect and as potential intestinal absorption enhancers. The cytotoxicity of all the evaluated compounds was evaluated against normal human skin fibroblast cells. Their anti-proliferative activity was also assessed against human cancer cell lines: T-lymphoblastic leukaemia cell line and breast adenocarcinoma cell line. One compound showed high selective cytotoxicity against human skin fibroblast cells and another compound possessed high cytotoxicity against breast adenocarcinoma cell line and skin fibroblast cells. Only one compound expressed anti-proliferative effect on leukaemia and breast adenocarcinoma cells without affecting the growth of normal cells, which should be promising in potential development of new drugs. Most of the target compounds showed minimal anti-proliferative activity (IC50>37μM), indicating they would have moderate cytotoxicity when administered as chemical absorption modifiers. The relationships between the lipophilicity/polarity and the chemical structure of the studied compounds as well as the relationships between their chemical structure and penetration enhancement effect are discussed in this article.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14051050
003      
CZ-PrNML
005      
20140411093006.0
007      
ta
008      
140401s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.steroids.2013.05.012 $2 doi
035    __
$a (PubMed)23707574
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Mrózek, Lech
245    10
$a New polyfluorothiopropanoyloxy derivatives of 5β-cholan-24-oic acid designed as drug absorption modifiers / $c L. Mrózek, L. Coufalová, L. Rárová, L. Plaček, R. Opatřilová, J. Dohnal, K. Kráľová, O. Paleta, V. Král, P. Drašar, J. Jampílek,
520    9_
$a A series of final six propanoyloxy derivatives of 5β-cholan-24-oic acid (tridecafluoroctylsulfanyl- and tridecafluoroctylsulfinylethoxycarbonylpropanoyloxy derivatives) as potential drug absorption promoters (skin penetration enhancers, intestinal absorption promoters) was generated by multistep synthesis. Structure confirmation of all generated compounds was accomplished by (1)H NMR, (13)C NMR, IR and MS spectroscopy methods. All the prepared compounds were analyzed using RP-TLC, and their lipophilicity (RM) was determined. The hydrophobicity (log P), solubility (logS), polar surface area (PSA) and molar volume (MV) of the studied compounds were also calculated. All the target compounds were tested for their in vitro transdermal penetration effect and as potential intestinal absorption enhancers. The cytotoxicity of all the evaluated compounds was evaluated against normal human skin fibroblast cells. Their anti-proliferative activity was also assessed against human cancer cell lines: T-lymphoblastic leukaemia cell line and breast adenocarcinoma cell line. One compound showed high selective cytotoxicity against human skin fibroblast cells and another compound possessed high cytotoxicity against breast adenocarcinoma cell line and skin fibroblast cells. Only one compound expressed anti-proliferative effect on leukaemia and breast adenocarcinoma cells without affecting the growth of normal cells, which should be promising in potential development of new drugs. Most of the target compounds showed minimal anti-proliferative activity (IC50>37μM), indicating they would have moderate cytotoxicity when administered as chemical absorption modifiers. The relationships between the lipophilicity/polarity and the chemical structure of the studied compounds as well as the relationships between their chemical structure and penetration enhancement effect are discussed in this article.
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a kyseliny cholové $x chemie $7 D002793
650    _2
$a pomocné látky $x chemická syntéza $x metabolismus $x toxicita $7 D005079
650    _2
$a fibroblasty $x účinky léků $x metabolismus $7 D005347
650    _2
$a lidé $7 D006801
650    _2
$a fluorované uhlovodíky $x chemická syntéza $x metabolismus $x toxicita $7 D006845
650    _2
$a hydrofobní a hydrofilní interakce $7 D057927
650    _2
$a intestinální absorpce $7 D007408
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a membrány umělé $7 D008567
650    _2
$a permeabilita $7 D010539
650    _2
$a propionáty $x chemická syntéza $x metabolismus $x toxicita $7 D011422
650    _2
$a kožní absorpce $7 D012869
650    _2
$a rozpustnost $7 D012995
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Coufalová, Lenka $u -
700    1_
$a Rárová, Lucie $u -
700    1_
$a Plaček, Lukáš $u -
700    1_
$a Opatřilová, Radka $u -
700    1_
$a Dohnal, Jiří $u -
700    1_
$a Kráľová, Katarína $u -
700    1_
$a Paleta, Oldřich $u -
700    1_
$a Král, Vladimír $u -
700    1_
$a Drašar, Pavel $u -
700    1_
$a Jampílek, Josef $u -
773    0_
$w MED00004438 $t Steroids $x 1878-5867 $g Roč. 78, č. 9 (2013), s. 832-44
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23707574 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140401 $b ABA008
991    __
$a 20140411093056 $b ABA008
999    __
$a ok $b bmc $g 1018186 $s 849630
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 78 $c 9 $d 832-44 $i 1878-5867 $m Steroids $n Steroids $x MED00004438
LZP    __
$a Pubmed-20140401

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...